Diagnosis and therapy of systemic mycoses in the immunosuppressed host.
D000380:Agranulocytosis / Q000150:complications; D000666:Amphotericin B / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy; D003453:Cryptococcosis / Q000175:diagnosis; D003596:Cytosine / Q000627:therapeutic use; D048909:Diabetes Complications; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D007165:Immunosuppression Therapy; D009091:Mucormycosis / Q000175:diagnosis; D009181:Mycoses / Q000209:etiology*; D009761:Nystatin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D005938:Glucocorticoids; D009761:Nystatin; D000666:Amphotericin B; D003596:Cytosine